Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Roden

Showing results (51-60 of 237) with videos related to

Pageof 24
Sort By:
Clinical Pharmacology and Therapeutics|January 1, 1994
Quinidine-enhanced beta-blockade during treatment with propafenone in extensive metabolizer human subjectsK E Mörike, D M Roden
American Heart Journal|February 1, 1985
QT prolongation and arrhythmia suppressionD M Roden, R L Woosley
Clinical Pharmacology and Therapeutics|December 16, 2015
Integrating electronic health record genotype and phenotype datasets to transform patient careD M Roden, J C Denny
Medical Toxicology and Adverse Drug Experience|November 1, 1989
A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?F A Fish, D M Roden
The American Journal of Cardiology|April 30, 1987
Pharmacologic causes of arrhythmogenic actions of antiarrhythmic drugsR L Woosley, D M Roden
The American Journal of Medicine|March 20, 1987
Effects of low potassium or magnesium concentrations on isolated cardiac tissueD M Roden, D H Iansmith
Handbook of Experimental Pharmacology|April 14, 2006
ProarrhythmiaD M Roden, M E Anderson
Clinical Pharmacology and Therapeutics|July 23, 2013
Genomic medicine, precision medicine, personalized medicine: what's in a name?D M Roden, R F Tyndale
Heart (British Cardiac Society)|August 24, 2000
The pause that refreshes, or does it? Mechanisms in torsades de pointesD M Roden, M E Anderson
Cardiovascular Research|February 26, 2000
A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiologyD M Roden, J R Balser
Pageof 24

Showing results (51-60 of 237) with videos related to

Sort By:
Pageof 24
Clinical Pharmacology and Therapeutics|January 1, 1994
Quinidine-enhanced beta-blockade during treatment with propafenone in extensive metabolizer human subjectsK E Mörike, D M Roden
American Heart Journal|February 1, 1985
QT prolongation and arrhythmia suppressionD M Roden, R L Woosley
Clinical Pharmacology and Therapeutics|December 16, 2015
Integrating electronic health record genotype and phenotype datasets to transform patient careD M Roden, J C Denny
Medical Toxicology and Adverse Drug Experience|November 1, 1989
A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?F A Fish, D M Roden
The American Journal of Cardiology|April 30, 1987
Pharmacologic causes of arrhythmogenic actions of antiarrhythmic drugsR L Woosley, D M Roden
The American Journal of Medicine|March 20, 1987
Effects of low potassium or magnesium concentrations on isolated cardiac tissueD M Roden, D H Iansmith
Handbook of Experimental Pharmacology|April 14, 2006
ProarrhythmiaD M Roden, M E Anderson
Clinical Pharmacology and Therapeutics|July 23, 2013
Genomic medicine, precision medicine, personalized medicine: what's in a name?D M Roden, R F Tyndale
Heart (British Cardiac Society)|August 24, 2000
The pause that refreshes, or does it? Mechanisms in torsades de pointesD M Roden, M E Anderson
Cardiovascular Research|February 26, 2000
A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiologyD M Roden, J R Balser
Pageof 24